Literature DB >> 35304386

The significance of the gut microbiome in post-COVID-19 gastrointestinal symptoms.

Temi Lampejo1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35304386      PMCID： PMC8966836          DOI： 10.7861/clinmed.Let.22.2.5

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   5.410


× No keyword cloud information.
  9 in total

1.  Use of broad-spectrum antibiotics and the development of irritable bowel syndrome.

Authors:  Armando A Villarreal; Frank J Aberger; Ryan Benrud; Jacob D Gundrum
Journal:  WMJ       Date:  2012-02

Review 2.  Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis.

Authors:  Hai-Ning Liu; Hao Wu; Yu-Zhuo Chen; Yan-Jie Chen; Xi-Zhong Shen; Tao-Tao Liu
Journal:  Dig Liver Dis       Date:  2017-01-21       Impact factor: 4.088

3.  COVID-19 infection causing residual gastrointestinal symptoms - a single UK centre case series.

Authors:  Joseph Cooney; Priscilla Appiahene; Ross Findlay; Lulia Al-Hillawi; Khizar Rafique; William Laband; Benjamin Shandro; Andrew Poullis
Journal:  Clin Med (Lond)       Date:  2022-02-01       Impact factor: 5.410

Review 4.  Recent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic review.

Authors:  Emily K Wright; Michael A Kamm; Shu Mei Teo; Michael Inouye; Josef Wagner; Carl D Kirkwood
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

5.  Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.

Authors:  Tao Zuo; Hui Zhan; Fen Zhang; Qin Liu; Eugene Y K Tso; Grace C Y Lui; Nan Chen; Amy Li; Wenqi Lu; Francis K L Chan; Paul K S Chan; Siew C Ng
Journal:  Gastroenterology       Date:  2020-06-26       Impact factor: 22.682

Review 6.  The gut microbiome and irritable bowel syndrome.

Authors:  Stacy Menees; William Chey
Journal:  F1000Res       Date:  2018-07-09

7.  Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome.

Authors:  Qin Liu; Joyce Wing Yan Mak; Qi Su; Yun Kit Yeoh; Grace Chung-Yan Lui; Susanna So Shan Ng; Fen Zhang; Amy Y L Li; Wenqi Lu; David Shu-Cheong Hui; Paul Ks Chan; Francis K L Chan; Siew C Ng
Journal:  Gut       Date:  2022-01-26       Impact factor: 23.059

8.  COVID-19 and the potential long-term impact on antimicrobial resistance.

Authors:  Timothy M Rawson; Luke S P Moore; Enrique Castro-Sanchez; Esmita Charani; Frances Davies; Giovanni Satta; Matthew J Ellington; Alison H Holmes
Journal:  J Antimicrob Chemother       Date:  2020-07-01       Impact factor: 5.790

Review 9.  Gastrointestinal manifestations in COVID-19.

Authors:  Jayani C Kariyawasam; Umesh Jayarajah; Rishdha Riza; Visula Abeysuriya; Suranjith L Seneviratne
Journal:  Trans R Soc Trop Med Hyg       Date:  2021-12-02       Impact factor: 2.184
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.